Avenue Therapeutics News

Avenue Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fortress Biotech, Inc.(8.0%)

Apr 18 04:11

Avenue Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Fortress Biotech, Inc.

Apr 18 04:10

Avenue Therapeutics | 8-K: Current report

Mar 30 02:43

Avenue Therapeutics | DEF 14C: Definitive information statements

Mar 19 05:01

Avenue Therapeutics | 10-K: Annual report

Mar 19 04:23

Avenue Therapeutics | 8-K: Current report

Mar 19 04:16

Avenue Therapeutics | 8-K: Current report

Mar 15 19:20

Avenue Therapeutics | PRE 14C: Preliminary information statement not related to a contested matter or merger/acquisition

Mar 9 05:38

Avenue Therapeutics | 8-K: Current report

Mar 9 05:19

Avenue Therapeutics | 8-K: Current report

Feb 24 05:25

Avenue Therapeutics | 424B3: Prospectus

Feb 3 00:46

Avenue Therapeutics | EFFECT: Others

Feb 2 19:05

Avenue Therapeutics | CORRESP: CORRESP

Jan 31 00:45

Avenue Therapeutics | UPLOAD: Others

Jan 30 00:45

Avenue Therapeutics | DEF 14C: Definitive information statements

Jan 29 21:03

Avenue Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Jan 25 05:15

Avenue Therapeutics | PRE 14C: Preliminary information statement not related to a contested matter or merger/acquisition

Jan 17 13:00

Avenue Therapeutics | 8-K: Current report

Jan 12 13:00

Avenue Therapeutics | 8-K: Current report

Jan 8 13:00

Avenue Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Fortress Biotech, Inc.

Jan 3 13:00